Author name: antonheyman

It contains dry ivy leaf extract (Hedera Helix) that has expectorant and spasmolytic actions. It is indicated for: Acute inflammation of the respiratory tract and for the improvement of symptoms of chronic-inflammatory bronchial disease. SEP price incl VAT is R45.00

MSD has launched of JANUVIA® (25 mg, 50 mg, 100 mg daily), a new oral antidiabetic agent for the treatment of type 2 diabetes. JANUVIA® contains sitagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor (incretin enhancer) that increases the levels of two incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP). These hormones play a

Novartis South Africa is pleased to announce the introduction of Galvus®Met effective from 17 October 2012. This is in addition to the Galvus® range, enhancing their metabolic portfolio. Here are the Galvus®Met options: Galvus Met 50mg/850mg tablets in 30’s and 60’s Galvus Met 50mg/1000mg tablets in 30’s and 60’s

Astellas Pharma has discontinued the 100g pack size of Locoid Crelo. However, the Locoid Crelo 30g pack size is still available.

n a concerted effort to ensure excellence and the successful implementation of the goals set in the Human Resources for Health Strategy, the Minister of Health, Dr Aaron Motsoaledi will on Tuesday, 6 November launch the Academy for Leadership and Management in Health Care to address skills gaps at all levels, including clinical and hospital

Launch of Co-Exforge – Novartis South Africa has launched Co-Exforge® effective from 23 October 2012. It includes: Co-Exforge® 5 mg/160 mg/12,5 mg Co-Exforge® 5 mg/160 mg/25 mg Co-Exforge® 10 mg/160 mg/12,5 mg Co-Exforge® 10 mg/160 mg/25 mg For any queries please contact the Novartis Customer Support Line on 0861 929 929

The South African Pharmacy Council is hosting the 1st Conference ever for pharmacy on 23 – 26 June 2013 in Sun City, North West Province, South Africa. This conference earmarks to bring all pharmacy professionals and friends of the profession to this prestigious event to share challenges and developments both nationally and internationally, to tackle

The effect of aspirin on prevention is a long-term effect and that not very much happens in the 5 years after you start taking aspirin. The preventive effects are really quite long-term. The dose that was tested was 600 mg/day. It looks like all of the gastrointestinal cancers might be quite substantially affected. There also

Taking nonsteroidal anti-inflammatory drugs (NSAIDs) appears to significantly lower the risk for developing several major forms of skin cancer, a new Danish study reveals. What’s more, the apparent protective impact of both prescription and nonprescription NSAIDs on skin cancer risk seems to be stronger the longer someone takes them. http://www.drugs.com/news/common-painkillers-may-help-prevent-skin-cancer-study-38435.html

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments. Thioridazine works through the dopamine receptor on the surface of the cancer cells in both leukemia and breast cancer patients. This means it may be possible